Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Nikhil Khushalani"'
Autor:
Andrew Haydon, Celeste Lebbe, Jose Lutzky, Gregory Daniels, Ragini Kudchadkar, Ann Silk, Nikhil Khushalani, Frances Collichio, Jean-Jaques Grob, Samantha Bowyer, Praveen Bommareddy, Andrew Hill, Danny Rischin, Daniel Brungs, Michael Migden, Matthew Fury, Jenny Lee, Muhammad Alamgeer, Dimitrios Colevas, Wanxing Chai-Ho, Piyush Sheladia, Shui He, Claudia Andreu-Vieyra
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/167192fa3f6d4054be25ce205537925e
Autor:
Yolanda Piña, Brittany R. Evernden, Nikhil Khushalani, Kim Margolin, Hussein Tawbi, Nam D. Tran, Robert Macaulay, Peter Forsyth, Edwin Peguero
Publikováno v:
SAGE Open Medical Case Reports, Vol 9 (2021)
The use of immune checkpoint inhibitors including ipilimumab and nivolumab has expanded for several tumors including melanoma brain metastasis. These have resulted in a growing spectrum of neurologic immune-related adverse events, including ones that
Externí odkaz:
https://doaj.org/article/11c1187894b547dd99a5dd993fc1c1a8
Autor:
Joseph Markowitz, Siqing Fu, Gregory Daniels, Lyudmila Bazhenova, Nikhil Khushalani, Zeynep Eroglu, Andrew Brohl, Heather Yeckes-Rodin, Lori McCormick, Michael Kurman, Mireille Gillings, Gloria Lee
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/f3529437fa1743ff965769eda42b8587
Autor:
John E. Mullinax, MacLean Hall, Sangeetha Prabhakaran, Jeffrey Weber, Nikhil Khushalani, Zeynep Eroglu, Andrew S. Brohl, Joseph Markowitz, Erica Royster, Allison Richards, Valerie Stark, Jonathan S. Zager, Linda Kelley, Cheryl Cox, Vernon K. Sondak, James J. Mulé, Shari Pilon-Thomas, Amod A. Sarnaik
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
PurposeAdoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) for metastatic melanoma can be highly effective, but attrition due to progression before TIL administration (32% in prior institutional experience) remains a limitation. We
Externí odkaz:
https://doaj.org/article/3e14ab4dede64fa39939188dae9bb51b
Autor:
Joseph M. Unger, Amy Darke, Megan Othus, Thach-Giao Truong, Nikhil Khushalani, Kari Kendra, Karl D. Lewis, Bryan Faller, Pauline Funchain, Elizabeth I. Buchbinder, Ahmad A. Tarhini, John M. Kirkwood, Elad Sharon, Vernon Sondak, Samantha R. Guild, Kenneth Grossmann, Antoni Ribas, Sapna P. Patel
Publikováno v:
JAMA oncology.
ImportanceA key issue for the adjuvant treatment of patients with melanoma is the assessment of the effect of treatment on relapse, survival, and quality of life (QOL).ObjectiveTo compare QOL in patients with resected melanoma at high risk for relaps
Autor:
Nikhil Khushalani, Renuka Iyer, Peter Loud, Peter Bushunow, Mateusz Opyrchal, Eric Kannisto, Araba Adjei, Sai Yendamuri, Kristopher Attwood, Santosh Patnaik, Austin Miller, Patrick Boland, Christos Fountzilas, Sarbajit Mukherjee, Usha Malhotra
Supplementary Figure F1 shows unsupervised hierarchical clustering of 29 cancer cases by their micro RNA expression profile
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a309df2541ec917db16cf72b82259ff4
https://doi.org/10.1158/1535-7163.22506631
https://doi.org/10.1158/1535-7163.22506631
Autor:
Nikhil Khushalani, Renuka Iyer, Peter Loud, Peter Bushunow, Mateusz Opyrchal, Eric Kannisto, Araba Adjei, Sai Yendamuri, Kristopher Attwood, Santosh Patnaik, Austin Miller, Patrick Boland, Christos Fountzilas, Sarbajit Mukherjee, Usha Malhotra
The purpose of our study was to evaluate the efficacy of a combination of pralatrexate plus oxaliplatin in advanced esophagogastric cancer (EGC), analyze the impact of polymorphisms in folate metabolism pathway genes on toxicity and efficacy of prala
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb544ebcc94edf5d413a0268ce9c1a3b
https://doi.org/10.1158/1535-7163.c.6538447.v1
https://doi.org/10.1158/1535-7163.c.6538447.v1
Autor:
Nikhil Khushalani, Renuka Iyer, Peter Loud, Peter Bushunow, Mateusz Opyrchal, Eric Kannisto, Araba Adjei, Sai Yendamuri, Kristopher Attwood, Santosh Patnaik, Austin Miller, Patrick Boland, Christos Fountzilas, Sarbajit Mukherjee, Usha Malhotra
Supplementary Table S1 is summarizing grade 3 or higher adverse events Supplementary Table S2 is listing the most common adverse events Supplementary Table S3 is summarizing the distribution of genotype and allele frequencies in patients Supplementar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b22d50388d2019e02300978b7226f64
https://doi.org/10.1158/1535-7163.22506625.v1
https://doi.org/10.1158/1535-7163.22506625.v1
Autor:
Nikhil Khushalani, David Gerber, Jeffery W. Clark, Wells Messersmith, Tricia Heinrichs, Nicole Zion, Jordan Berlin
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:QIM22-197
Autor:
Celeste Lebbe, Shruthi Ravimohan, Antara Datta, Aparna Chhibber, Eva Muñoz Couselo, Caio Pereira, Shahneen Sandhu, Ming Zhou, Brendan Curti, Nikhil Khushalani, Matthew Taylor, Alfonsus Van Den Eertwegh, Ute Hoch, Georgina Long AO, Yull Arriaga, Adi Diab, Helen Gogas
Publikováno v:
Late-Breaking Abstracts.